Peter Reimer
Impact in
-
- Lymphoma Diagnosis and Treatment
- Dermatology top 1%
- Cutaneous lymphoproliferative disorders research
Papers in
-
- Lymphoma Diagnosis and Treatment 20
- Oncology 16
- Viral-associated cancers and disorders 7
- CAR-T cell therapy research 5
- Co-authors
- Florian Weißinger (11 shared papers)Volker Kunzmann (6 shared papers)Martin Wilhelm (11 shared papers)Thomas Rüediger (5 shared papers)Thomas Rüdiger (11 shared papers)Susanne Eckstein (1 shared paper)Hans‐Peter Tony (1 shared paper)Eva Geissinger (11 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Blood (5 papers)Annals of Hematology (3 papers)Radiology (2 papers)RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (2 papers)
- Partner nations
- GermanyUnited StatesHungary
In The Last Decade
Peter Reimer
45 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 104
- Pathology and Forensic Medicine 859
- Dermatology 344
- Immunology 726
- Oncology 822
- Hematology 218
Countries citing papers authored by Peter Reimer
This map shows the geographic impact of Peter Reimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Reimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Reimer more than expected).
Fields of papers citing papers by Peter Reimer
This network shows the impact of papers produced by Peter Reimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Reimer. The network helps show where Peter Reimer may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Reimer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 470 | |
| 2 | 2008 | 291 | |
| 3 | 2007 | 128 | |
| 4 | 2003 | 124 | |
| 5 | 2003 | 116 | |
| 6 | 2007 | 112 | |
| 7 | 2010 | 107 | |
| 8 | 2017 | 104 | |
| 9 | 2014 | 61 | |
| 10 | 2018 | 53 | |
| 11 | 2016 | 52 | |
| 12 | 2004 | 50 | |
| 13 | 2017 | 50 | |
| 14 | 2022 | 46 | |
| 15 | 2010 | 43 | |
| 16 | 2004 | 41 | |
| 17 | 1994 | 37 | |
| 18 | 2018 | 33 | |
| 19 | 2010 | 29 | |
| 20 | 2003 | 23 |
About Peter Reimer
Peter Reimer is a scholar working on Pathology and Forensic Medicine, Oncology, Dermatology, Immunology and Surgery, having authored 47 papers that have together received 2.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (20 papers), Cutaneous lymphoproliferative disorders research (10 papers), Viral-associated cancers and disorders (7 papers), T-cell and Retrovirus Studies (6 papers), CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (4 papers), Acute Myeloid Leukemia Research (3 papers) and CNS Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (859 citations), Dermatology (344 citations), Immunology (726 citations), Oncology (822 citations) and Hematology (218 citations). Peter Reimer has collaborated with scholars based in Germany, United States and Hungary. Frequent co-authors include Florian Weißinger, Volker Kunzmann, Martin Wilhelm, Thomas Rüediger, Thomas Rüdiger, Susanne Eckstein, Hans‐Peter Tony, Eva Geissinger, Hans Konrad Müller‐Hermelink and Norbert Schmitz. Their work appears in journals such as Journal of Clinical Oncology, Blood, Annals of Hematology, Radiology and RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.